References
- KostrikenRStrathernJNKlarAJHicksJBHeffronFA site-specific endonuclease essential for mating-type switching in Saccharomyces cerevisiaeCell1983351671746313222
- LutfiyyaLLJohnstonMTwo zinc-finger-containing repressors are responsible for glucose repression of SUC2 expressionMol Cell Biol199616479047978756637
- SudarsanamPWinstonFThe Swi/Snf family nucleosome-remodeling complexes and transcriptional controlTrends Genet20001634535110904263
- Perez-MartinJJohnsonADThe C-terminal domain of Sin1 interacts with the SWI-SNF complex in yeastMol Cell Biol199818415741649632800
- KingstonRENarlikarGJATP-dependent remodeling and acetylation as regulators of chromatin fluidityGenes Dev1999132339235210500090
- KingstonREBunkerCAImbalzanoANRepression and activation by multiprotein complexes that alter chromatin structureGenes Dev1996109059208608939
- TurnerBMReading signals on the nucleosome with a new nomenclature for modified histonesNat Struct Mol Biol20051211011215702071
- KornbergRDLorchYChromatin-modifying and -remodeling complexesCurr Opin Genet Dev1999914815110322131
- AlbertsBJohnsonALewisJRaffMRobertsKWalterPMolecular Biology of the Cell4th edNew York CityGarland Science2002
- KothandapaniAGopalakrishnanKKahaliBReismanDPatrickSMDownregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicityExp Cell Res20123181973198622721696
- ReismanDNSciarrottaJWangWFunkhouserWKWeissmanBELoss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosisCancer Res20036356056612566296
- FukuokaJFujiiTShihJHChromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancerClin Cancer Res2004104314432415240517
- InoueHGiannakopoulosSParkhurstCNTarget genes of the largest human SWI/SNF complex subunit control cell growthBiochem J2011434839221118156
- ShainAHSalariKGiacominiCPPollackJRIntegrative genomic and functional profiling of the pancreatic cancer genomeBMC Genomics20131462424041470
- MinottiGMennaPSalvatorelliECairoGGianniLAnthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicityPharmacol Rev20045618522915169927
- XiaLJaafarLCashikarAFlores-RozasHIdentification of genes required for protection from doxorubicin by a genome-wide screen in Saccharomyces cerevisiaeCancer Res200767114111141818056469
- KolodnerRDAlaniEMismatch repair and cancer susceptibilityCurr Opin Biotechnol199455855947765740
- TishkoffDXBoergerALBertrandPIdentification and characterization of Saccharomyces cerevisiae EXO1, a gene encoding an exonuclease that interacts with MSH2Proc Natl Acad Sci U S A199794748774929207118
- Lee TitsworthWMuradGJHohBLRahmanMFighting fire with fire: the revival of thermotherapy for gliomasAnticancer Res20143456557424510985
- GehlJBoesgaardMPaaskeTVittrup JensenBDombernowskyPCombined doxorubicin and paclitaxel in advanced breast cancer: effective and cardiotoxicAnn Oncol199676876938905026
- van KuilenburgABMaringJGEvaluation of 5-fluorouracil pharmacokinetic models and therapeutic drug monitoring in cancer patientsPharmacogenomics20131479981123651027
- O’ShaughnessyJAFishermanJSCowanKHCombination paclitaxel (Taxol) and doxorubicin therapy for metastatic breast cancerSemin Oncol19942119237939757
- OzkanMBerkVKaplanMAGemcitabine and cisplatin combination chemotherapy in triple negative metastatic breast cancer previously treated with a taxane/anthracycline chemotherapy; multicenter experienceNeoplasma201259384222103897
- KohailHShehataSMansourOA phase 2 study of the combination of gemcitabine and cisplatin in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines with/without taxanesHematol Oncol Stem Cell Ther20125424822446614
- SiddikZHCisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene2003227265727914576837
- Saccharomyces Genome Database [database on the Internet]Stanford, CAStanford University Available from: http://www.yeastgenome.orgAccessed 28 October, 2014
- RichmondEPetersonCLFunctional analysis of the DNA-stimulated ATPase domain of yeast SWI2/SNF2Nucleic Acids Res199624368536928871545
- DrorVWinstonFThe Swi/Snf chromatin remodeling complex is required for ribosomal DNA and telomeric silencing in Saccharomyces cerevisiaeMol Cell Biol2004248227823515340082
- MalikSChaurasiaPLahudkarSUpretyBBhaumikSRRad26p regulates the occupancy of histone H2A-H2B dimer at the active genes in vivoNucleic Acids Res2012403348336322199252
- ZhangHRichardsonDORobertsDNThe Yaf9 component of the SWR1 and NuA4 complexes is required for proper gene expression, histone H4 acetylation, and Htz1 replacement near telomeresMol Cell Biol2004249424943615485911
- GengFCaoYLaurentBCEssential roles of Snf5p in Snf-Swi chromatin remodeling in vivoMol Cell Biol2001214311432011390659
- StefanssonOAVillanuevaAVidalAMartiLEstellerMBRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancerEpigenetics201271225122923069641
- MuchardtCSardetCBourachotBOnufrykCYanivMA human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrmNucleic Acids Res199523112711327739891
- MuchardtCYanivMWhen the SWI/SNF complex remodels 1/4 the cell cycleOncogene2001203067307511420722
- NumataMMorinagaSWatanabeTThe clinical significance of SWI/SNF complex in pancreatic cancerInt J Oncol20124240341023229642
- HessonLBPatilVSloaneMAReassembly of nucleosomes at the MLH1 promoter initiates resilencing following decitabine exposurePLoS Genet20139e100363623935509